CCP
Clough Capital Partners Portfolio holdings
AUM
$997M
This Quarter Return
+13.15%
1 Year Return
+37.42%
3 Year Return
+130.83%
5 Year Return
+251.5%
10 Year Return
+1,002%
AUM
$910M
AUM Growth
+$910M
(+0.62%)
Cap. Flow
-$63.1M
Cap. Flow
% of AUM
-6.94%
Top 10 Holdings %
Top 10 Hldgs %
35.49%
Holding
205
New
13
Increased
31
Reduced
42
Closed
88
Top Buys
| 1 |
Eli Lilly
LLY
|
$20.5M |
| 2 |
Palo Alto Networks
PANW
|
$20.3M |
| 3 |
ASML
ASML
|
$17.1M |
| 4 |
SharkNinja
SN
|
$14.2M |
| 5 |
Ecolab
ECL
|
$13.9M |
Top Sells
| 1 |
Alphabet (Google) Class C
GOOG
|
$20.2M |
| 2 |
Sanofi
SNY
|
$16M |
| 3 |
Wynn Resorts
WYNN
|
$14.7M |
| 4 |
General Dynamics
GD
|
$9.75M |
| 5 |
HDFC Bank
HDB
|
$9.09M |
Sector Composition
| 1 | Technology | 24.95% |
| 2 | Consumer Discretionary | 16.9% |
| 3 | Healthcare | 15.34% |
| 4 | Industrials | 12.01% |
| 5 | Financials | 7.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
New Fortress Energy
NFE
$675M
| $560K | 0.06% | 18,298 +9,103 | +99% | +$278K |
|
102
Hologic
HOLX
$14.9B
| $558K | 0.06% | 7,160 | – | – |
|
103
Chart Industries
GTLS
$8.96B
| $535K | 0.06% | +3,248 | New | +$535K |
|
104
AbbVie
ABBV
$372B
| $519K | 0.06% | 2,850 | – | – |
|
105
IMAX
IMAX
$1.54B
| $516K | 0.06% | +31,931 | New | +$516K |
|
|
NARI
106
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $494K | 0.05% | +10,291 | New | +$494K |
|
107
VICI Properties
VICI
$36B
| $492K | 0.05% | 16,500 | – | – |
|
108
Humacyte
HUMA
$245M
| $486K | 0.05% | 156,263 +27,008 | +21% | +$84K |
|
109
Illinois Tool Works
ITW
$77.1B
| $481K | 0.05% | 1,793 | – | – |
|
110
Select Water Solutions
WTTR
$895M
| $470K | 0.05% | 50,944 +10,598 | +26% | +$97.8K |
|
111
Gilead Sciences
GILD
$140B
| $461K | 0.05% | 6,300 | – | – |
|
112
Prudential Financial
PRU
$38.6B
| $387K | 0.04% | 3,300 | – | – |
|
113
Lockheed Martin
LMT
$106B
| $371K | 0.04% | 815 | – | – |
|
114
argenx
ARGX
$43.6B
| $352K | 0.04% | 895 -11,596 | -93% | -$4.57M |
|
115
BioMarin Pharmaceuticals
BMRN
$11.2B
| $313K | 0.03% | 3,580 | – | – |
|
116
B2Gold
BTG
$5.46B
| $156K | 0.02% | +59,600 | New | +$156K |
|
117
Kinross Gold
KGC
$25.5B
| $154K | 0.02% | 25,200 +4,702 | +23% | +$28.8K |
|
|
ACP
118
abrdn Income Credit Strategies Fund
ACP
$745M
| – | – | -299,577 | Closed | -$2.04M |
|
119
Aehr Test Systems
AEHR
$746M
| – | – | -13,473 | Closed | -$357K |
|
120
American Electric Power
AEP
$59.4B
| – | – | -4,591 | Closed | -$373K |
|
121
Amgen
AMGN
$155B
| – | – | -3,762 | Closed | -$1.08M |
|
122
Air Products & Chemicals
APD
$65.5B
| – | – | -6,883 | Closed | -$1.88M |
|
123
Arcos Dorados Holdings
ARCO
$1.47B
| – | – | -29,499 | Closed | -$374K |
|
124
Ardelyx
ARDX
$1.53B
| – | – | -68,422 | Closed | -$424K |
|
125
Avista
AVA
$2.96B
| – | – | -9,496 | Closed | -$339K |
|